We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
30 Jan 2023 - 02 Feb 2023

MRI Shows Brain Inflammation in Vivo for the First Time

By MedImaging International staff writers
Posted on 30 May 2022
Print article
Image: Researchers have obtained images of the activation of microglia and astrocytes using dw-MRI (Photo courtesy of Pexels)
Image: Researchers have obtained images of the activation of microglia and astrocytes using dw-MRI (Photo courtesy of Pexels)

Degenerative brain diseases such as Alzheimer's and other dementias, Parkinson's or multiple sclerosis are a pressing and difficult problem to address. Sustained activation of two types of brain cells, microglia and astrocytes leads to chronic inflammation in the brain that is one of the causes of neurodegeneration and contributes to its progression. However, there is a lack of non-invasive approaches capable of specifically characterizing brain inflammation in vivo. Now, researchers have obtained for the first time images of the activation of microglia and astrocytes, the two types of cells involved in neuroinflammation, using diffusion-weighted magnetic resonance (dw-MRI).

An innovative strategy developed by researchers at the Institute of Neurosciences CSIC-UMH (Alicante, Spain) has made this important breakthrough possible which may be crucial to change the course of the study and treatment of neurodegenerative diseases. The research has demonstrated that dw-MRI can noninvasively and differentially detect the activation of microglia and astrocytes, two types of brain cells that are at the basis of neuroinflammation and its progression.

The current gold standard for specifically characterizing brain inflammation in vivo is positron emission tomography (PET), but it is difficult to generalize and is associated with exposure to ionizing radiation, so its use is limited in vulnerable populations and in longitudinal studies, which require the use of PET repeatedly over a period of years, as is the case in neurodegenerative diseases. Another drawback of PET is its low spatial resolution, which makes it unsuitable for imaging small structures, with the added drawback that inflammation-specific radiotracers are expressed in multiple cell types (microglia, astrocytes and endothelium), making it impossible to differentiate between them.

In the face of these drawbacks, dw-MRI has the unique ability to image brain microstructure in vivo noninvasively and with high resolution by capturing the random movement of water molecules in the brain parenchyma to generate contrast in MRI images. In addition to demonstrating using dw-MRI allows imaging of microglial and astrocyte activation in the gray matter of the brain, the researchers have also shown that this technique is sensitive and specific for detecting inflammation with and without neurodegeneration, so that both conditions can be differentiated. In addition, dw-MRI makes it possible to discriminate between inflammation and demyelination characteristic of multiple sclerosis.

To validate the model, the researchers used an established paradigm of inflammation in rats based on intracerebral administration of lipopolysaccharide (LPS). In this paradigm, neuronal viability and morphology are preserved, while inducing, first, an activation of microglia (the brain's immune system cells), and in a delayed manner, an astrocyte response. This temporal sequence of cellular events allows glial responses to be transiently dissociated from neuronal degeneration and the signature of reactive microglia investigated independently of astrogliosis.

To isolate the imprint of astrocyte activation, the researchers repeated the experiment by pretreating the animals with an inhibitor that temporarily ablates about 90% of microglia. Subsequently using an established paradigm of neuronal damage, they tested whether the model was able to unravel neuroinflammatory "footprints" with and without concomitant neurodegeneration. Finally, the researchers used an established paradigm of demyelination, based on focal administration of lysolecithin, to demonstrate that the biomarkers developed do not reflect the tissue alterations frequently found in brain disorders.

"This is the first time it has been shown that the signal from this type of MRI (dw-MRI) can detect microglial and astrocyte activation, with specific footprints for each cell population. This strategy we have used reflects the morphological changes validated post-mortem by quantitative immunohistochemistry," the researchers noted.

Related Links:
Institute of Neurosciences CSIC-UMH

Gold Supplier
SBRT Phantom with Removable Spine
E2E SBRT Phantom with Removable Spine Model 036S-CVXX-xx
New
Digital Color Doppler Ultrasound
EC100A
New
Silver Supplier
Pocket-Size Fetal Doppler
BT-220220C/BT-220L
New
All-Digital PET/CT System
Omni Legend

Print article
CIRS -  MIRION

Channels

Ultrasound

view channel
Image: A combination of ultrasound and nanobubbles allows cancerous tumors to be destroyed without surgery (Photo courtesy of Tel Aviv University)

Ultrasound Combined With Nanobubbles Enables Removal of Tumors Without Surgery

The prevalent method of cancer treatment is surgical removal of the tumor, in combination with complementary treatments such as chemotherapy and immunotherapy. Therapeutic ultrasound to destroy the cancerous... Read more

General/Advanced Imaging

view channel
Image: Ultra-high-resolution photon-counting CT reveals bronchiolectasis (Photo courtesy of Medical University of Vienna)

Photon-Counting CT Shows More Post-COVID-19 Lung Damage

Photon-counting detector (PCD) CT has emerged in the last decade as a promising imaging tool. It works by converting X-ray photons directly into an electrical signal. This avoids the intermediate step... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.